This is a preprint.
The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians
- PMID: 38076854
- PMCID: PMC10705662
- DOI: 10.1101/2023.11.07.23298092
The non-coding GBA1 rs3115534 variant is associated with REM sleep behavior disorder in Nigerians
Update in
-
GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians.Mov Disord. 2024 Apr;39(4):728-733. doi: 10.1002/mds.29753. Epub 2024 Feb 23. Mov Disord. 2024. PMID: 38390630 Free PMC article.
Abstract
Background: Damaging coding variants in GBA1 are a genetic risk factor for rapid eye movement sleep behavior disorder (RBD), which is a known early feature of synucleinopathies. Recently, a population-specific non-coding variant (rs3115534) was found to be associated with PD risk and earlier disease onset in individuals of African ancestry.
Objectives: To investigate whether the GBA1 rs3115534 PD risk variant is associated with RBD.
Methods: We studied 709 persons with PD and 776 neurologically healthy controls from Nigeria. The GBA1 rs3115534 risk variant status was imputed from previous genotyping for all. Symptoms of RBD were assessed with the RBD screening questionnaire (RBDSQ).
Results: The non-coding GBA1 rs3115534 risk variant is associated with possible RBD in individuals of Nigerian origin (Beta = 0.3640, SE = 0.103, P =4.093e-04), as well as after adjusting for PD status (Beta = 0.2542, SE = 0.108, P = 0.019) suggesting that this variant may have the same downstream consequences as GBA1 coding variants.
Conclusions: We show that the non-coding GBA1 rs3115534 risk variant is associated with increased RBD symptomatology in Nigerians with PD. Further research is required to assess association with polysomnography-defined RBD.
Keywords: GBA1; Genetics; Nigeria; Nigerians; Parkinson’s disease; RBD; REM parasomnia; REM sleep behavior disorder; rs3115534; sub-Saharan Africa.
Conflict of interest statement
M.A.N.’s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the National Institutes of Health to support open science research. M.A.N. also currently serves on the scientific advisory board at Clover Therapeutics and is an advisor and scientific founder at Neuron23 Inc.
References
-
- Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744–748. doi: 10.1016/j.sleep.2012.10.009 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources